Age and acute myeloid leukemia
Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Stephen H. Petersdorf(Fred Hutch Cancer Center), Cheryl L. Willman(Mayo Clinic), Holly Gundacker(Seattle Cancer Care Alliance), Marilyn L. Slovak(City Of Hope National Medical Center), David R. Head(University of Southern California), Jeanne E. Anderson, John E. Godwin(Providence Portland Medical Center)
Cited by 1,354
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k